DelveInsight’s “Pouchitis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Pouchitis, historical and forecasted epidemiology as well as the Pouchitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. The Pouchitis market report provides current treatment practices, emerging drugs, Pouchitis market share of the individual therapies, and current and forecasted Pouchitis market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Pouchitis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Pouchitis market.
Key Benefits of the Report:
-
The report covers the descriptive overview of Pouchitis, explaining its causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
-
Comprehensive insight has been provided into the Pouchitis epidemiology and treatment in the 7MM
-
Additionally, an all-inclusive account of both the current and emerging therapies for Pouchitis is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
-
A detailed review of the Pouchitis market; historical and forecasted is included in the report, covering drug outreach in the 7MM
-
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Pouchitis market
Got queries? Click here to know more about the Pouchitis Market Landscape
Pouchitis Overview
Pouchitis is inflammation that occurs in the lining of a pouch created during surgery to treat ulcerative colitis or certain other diseases. Many people with ulcerative colitis need to have their diseased colon removed and the bowel reconnected with a procedure called ileoanal anastomosis (J-pouch) surgery. Pouchitis is an umbrella term for inflammation of the ileal pouch, an artificial rectum surgically created out of the ileum (the last section of the small intestine) in patients who have undergone a proctocolectomy or total colectomy (removal of the colon and rectum).[1] The ileal pouch-anal anastomosis is created in the management of patients with ulcerative colitis, indeterminate colitis, familial adenomatous polyposis, cancer, or rarely, other colitis. A variety of mechanisms can be the cause of pouchitis including inflammatory factors such as a dysbiosis sparked inflammation or Crohn’s disease of the pouch, surgical causes including surgical join leaks and pelvic sepsis, or infectious from Clostridium difficile (C Diff) or Cytomegalovirus (CMV). It is possible to have more than one factor causing pouch inflammation at the same time
Pouchitis Epidemiology Insights:
-
The incidence of a first episode of pouchitis at 1, 5, and 10 years post-operatively is 15%, 33%, and 45% respectively.
-
Patients with pouchitis typically present with bloody diarrhea, urgency in passing stools, or discomfort while passing stools. The loss of blood and/or dehydration resulting from the frequent stools will frequently result in nausea. Extreme cramping and pain can occur with pouchitis.
-
Among patients who have undergone ileal pouch-anal anastomosis (IPAA), the reported incidence of pouchitis ranges from 20 to 50 percent [2-6]. Pouchitis occurs more frequently among patients who have undergone an IPAA for ulcerative colitis than those with familial adenomatous polyposis.
Pouchitis Epidemiological Segmentation
-
Pouchitis prevalent cases
-
Pouchitis incident cases
-
Pouchitis diagnosed cases
-
Pouchitis treatment cases
-
Pouchitis cases based on age
Pouchitis Market Outlook
The Pouchitis market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Pouchitis market trends by analyzing the impact of current Pouchitis therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the Pouchitis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Pouchitis market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the Pouchitis market in 7MM is expected to witness a major change in the study period 2019-2032.
Learn more by requesting for sample @ Pouchitis Market Landscape
Table of Contents
-
Key Insights
-
Report Introduction
-
Executive Summary of Pouchitis Market
-
Pouchitis Disease Background and Overview
-
Pouchitis Epidemiology and patient population
-
The United States
-
EU 5
-
Pouchitis Market Emerging Therapies
-
Pouchitis Market Cancer Market Outlook
-
Market Access and Reimbursement of Therapies
-
Appendix
-
Pouchitis Market Report Methodology
-
DelveInsight Capabilities
-
Disclaimer
-
About DelveInsight
Click here to read more about Pouchitis Market Landscape
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services